INTERNATIONAL PATENT: SALUBRIS (CHENGDU) BIOTECH CO., LTD., 信立泰（成都）生物技术有限公司 FILES APPLICATION FOR "BISPECIFIC ANTIBODY TARGETING GPC3 OR ANTIGEN-BINDING FRAGMENT AND USE THEREOF"

GENEVA, March 8 -- SALUBRIS (CHENGDU) BIOTECH CO., LTD. (No.1, 3rd Floor, Building 4, No. 1, Keyuan South Road, High-tech DistrictChengdu, Sichuan 610041), 信立泰（成都）生物技术有限公司 (中国四川省成都市高新区科园南路1号4栋3层1号) filed a patent application (PCT/CN2024/116187) for "BISPECIFIC ANTIBODY TARGETING GPC3 OR ANTIGEN-BINDING FRAGMENT AND USE THEREOF" on Sep 01, 2024. With publication no. WO/2025/045242, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted unde...